• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

危重症患者复杂胸膜疾病的管理

Management of complex pleural disease in the critically ill patient.

作者信息

Hu Kurt, Chopra Amit, Kurman Jonathan, Huggins J Terrill

机构信息

Division of Pulmonary and Critical Care Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.

Division of Pulmonary and Critical Care Medicine, Albany Medical College, Albany, NY, USA.

出版信息

J Thorac Dis. 2021 Aug;13(8):5205-5222. doi: 10.21037/jtd-2021-31.

DOI:10.21037/jtd-2021-31
PMID:34527360
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8411157/
Abstract

Disorders of the pleural space are quite common in the critically ill patient. They are generally associated with the underlying illness. It is sometimes difficult to assess for pleural space disorders in the ICU given the instability of some patients. Although the portable chest X-ray remains the primary modality of diagnosis for pleural disorders in the ICU. It can be nonspecific and may miss subtle findings. Ultrasound has become a useful tool to the bedside clinician to aid in diagnosis and management of pleural disease. The majority of pleural space disorders resolve as the patient's illness improves. There remain a few pleural processes that need specific therapies. While uncomplicated parapneumonic effusions do not have their own treatments. Those that progress to become a complex infected pleural space can have its individual complexity in therapy. Chest tube drainage remains the cornerstone in therapy. The use of intrapleural fibrinolytics has decreased the need for surgical referral. A large hemothorax or pneumothorax in patients admitted to the ICU represent medical emergencies and require emergent action. In this review we focus on the management of commonly encountered complex pleural space disorders in critically ill patients such as complicated pleural space infections, hemothoraces and pneumothoraces.

摘要

胸膜腔疾病在危重症患者中相当常见。它们通常与基础疾病相关。鉴于一些患者病情不稳定,在重症监护病房(ICU)有时难以评估胸膜腔疾病。尽管便携式胸部X线检查仍是ICU中胸膜疾病的主要诊断方式,但它可能不具有特异性,且可能遗漏细微的发现。超声已成为床边临床医生辅助诊断和管理胸膜疾病的有用工具。随着患者病情改善,大多数胸膜腔疾病会得到缓解。仍有一些胸膜病变需要特定的治疗。虽然单纯性类肺炎性胸腔积液没有其自身的治疗方法,但那些进展为复杂感染性胸膜腔的疾病在治疗上会有其个体复杂性。胸腔闭式引流仍然是治疗的基石。胸膜腔内使用纤维蛋白溶解剂减少了手术转诊的需求。入住ICU的患者出现大量血胸或气胸属于医疗紧急情况,需要紧急处理。在本综述中,我们重点关注危重症患者中常见的复杂胸膜腔疾病的管理,如复杂性胸膜腔感染、血胸和气胸。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5569/8411157/e0399b04fc65/jtd-13-08-5205-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5569/8411157/5a3fc7516bd3/jtd-13-08-5205-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5569/8411157/216a94ea2f37/jtd-13-08-5205-vid1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5569/8411157/3587ceeb25ae/jtd-13-08-5205-vid2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5569/8411157/d247c535fc79/jtd-13-08-5205-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5569/8411157/db95f602b8a6/jtd-13-08-5205-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5569/8411157/b68eff9cb1b0/jtd-13-08-5205-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5569/8411157/effe6281bc16/jtd-13-08-5205-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5569/8411157/38904cfea491/jtd-13-08-5205-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5569/8411157/f8d1acc33de0/jtd-13-08-5205-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5569/8411157/e0399b04fc65/jtd-13-08-5205-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5569/8411157/5a3fc7516bd3/jtd-13-08-5205-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5569/8411157/216a94ea2f37/jtd-13-08-5205-vid1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5569/8411157/3587ceeb25ae/jtd-13-08-5205-vid2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5569/8411157/d247c535fc79/jtd-13-08-5205-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5569/8411157/db95f602b8a6/jtd-13-08-5205-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5569/8411157/b68eff9cb1b0/jtd-13-08-5205-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5569/8411157/effe6281bc16/jtd-13-08-5205-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5569/8411157/38904cfea491/jtd-13-08-5205-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5569/8411157/f8d1acc33de0/jtd-13-08-5205-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5569/8411157/e0399b04fc65/jtd-13-08-5205-f8.jpg

相似文献

1
Management of complex pleural disease in the critically ill patient.危重症患者复杂胸膜疾病的管理
J Thorac Dis. 2021 Aug;13(8):5205-5222. doi: 10.21037/jtd-2021-31.
2
Thoracoscopy for empyema and hemothorax.胸腔镜治疗脓胸和血胸。
Chest. 1996 Jan;109(1):18-24. doi: 10.1378/chest.109.1.18.
3
Pleural effusions in critically ill patients.危重症患者的胸腔积液
Respiration. 2008;76(3):241-8. doi: 10.1159/000143108. Epub 2008 Sep 25.
4
Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.胸膜内纤维蛋白溶解疗法与安慰剂或不同的纤维蛋白溶解剂在治疗成人肺炎旁胸腔积液和脓胸中的比较。
Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD002312. doi: 10.1002/14651858.CD002312.pub4.
5
[Using of fibrinolytics in the treatment of complicated parapneumonic effusion and empyema in children].[纤溶剂在儿童复杂性肺炎旁胸腔积液和脓胸治疗中的应用]
Tuberk Toraks. 2003;51(3):320-4.
6
Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema.胸膜内纤维蛋白溶解疗法在复杂性类肺炎性胸腔积液和脓胸治疗中作用的最新进展
Acta Med Indones. 2012 Jul;44(3):258-64.
7
The diagnosis and management of pleural effusions in the ICU.ICU 中胸腔积液的诊断和处理。
J Intensive Care Med. 2013 Jan-Feb;28(1):24-36. doi: 10.1177/0885066611403264. Epub 2011 Nov 11.
8
Emergencies in pleural diseases.胸膜疾病中的急症
Rev Clin Esp (Barc). 2013 Jun-Jul;213(5):242-50. doi: 10.1016/j.rce.2012.11.006. Epub 2012 Dec 20.
9
Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema.胸膜内纤维蛋白溶解疗法与保守治疗在成人肺炎旁胸腔积液和脓胸治疗中的比较
Cochrane Database Syst Rev. 2008 Apr 16(2):CD002312. doi: 10.1002/14651858.CD002312.pub3.
10
[Current value of intrapleural fibrinolysis in the treatment of exudative fibrinous pleural effusions in pleural empyema and hemothorax].[胸膜内纤维蛋白溶解疗法在治疗脓胸和血胸所致渗出性纤维蛋白性胸腔积液中的当前价值]
Pneumologie. 1999 Aug;53(8):373-84.

引用本文的文献

1
A rare presentation of pleural pseudocyst in chronic calcific pancreatitis: A case report.慢性钙化性胰腺炎中胸膜假性囊肿的罕见表现:一例报告。
Radiol Case Rep. 2025 Mar 8;20(5):2412-2417. doi: 10.1016/j.radcr.2025.01.094. eCollection 2025 May.
2
Unraveling the Predictive Potential of Rapid Scoring in Pleural Infection: A Critical Review.剖析胸膜感染快速评分的预测潜力:一项批判性综述
Cureus. 2023 Sep 1;15(9):e44515. doi: 10.7759/cureus.44515. eCollection 2023 Sep.

本文引用的文献

1
Morbidity and 30-day mortality after decortication for parapneumonic empyema and pleural effusion among patients in the Society of Thoracic Surgeons' General Thoracic Surgery Database.在胸外科医师协会普通胸外科数据库中,患者因肺炎旁胸腔积液和胸腔积液行胸膜剥脱术后的发病率及30天死亡率。
J Thorac Cardiovasc Surg. 2019 Mar;157(3):1288-1297.e4. doi: 10.1016/j.jtcvs.2018.10.157. Epub 2018 Nov 28.
2
Pleural manometry: techniques, applications, and pitfalls.胸腔测压法:技术、应用及陷阱
J Thorac Dis. 2020 May;12(5):2759-2770. doi: 10.21037/jtd.2020.04.04.
3
Intrapleural Fibrinolytic Therapy versus Early Medical Thoracoscopy for Treatment of Pleural Infection. Randomized Controlled Clinical Trial.
胸腔内纤维蛋白溶解治疗与早期内科胸腔镜治疗胸腔感染。随机对照临床试验。
Ann Am Thorac Soc. 2020 Aug;17(8):958-964. doi: 10.1513/AnnalsATS.202001-076OC.
4
Diagnostic Accuracy of Thoracic Ultrasonography to Differentiate Transudative From Exudative Pleural Effusion.胸腔超声对胸水中渗出液与漏出液的鉴别诊断准确性。
Chest. 2020 Aug;158(2):692-697. doi: 10.1016/j.chest.2020.02.051. Epub 2020 Mar 17.
5
Multiplex bacterial polymerase chain reaction in a cohort of patients with pleural effusion.对一组胸腔积液患者进行多重细菌聚合酶链反应。
BMC Infect Dis. 2020 Feb 1;20(1):99. doi: 10.1186/s12879-020-4793-6.
6
Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.胸膜内纤维蛋白溶解疗法与安慰剂或不同的纤维蛋白溶解剂在治疗成人肺炎旁胸腔积液和脓胸中的比较。
Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD002312. doi: 10.1002/14651858.CD002312.pub4.
7
Comparison of intrapleural use of urokinase and tissue plasminogen activator/DNAse in pleural infection.胸膜内使用尿激酶与组织纤溶酶原激活剂/脱氧核糖核酸酶治疗胸膜感染的比较
ERJ Open Res. 2019 Sep 10;5(3). doi: 10.1183/23120541.00084-2019. eCollection 2019 Jul.
8
Outcomes of Operative and Nonoperative Treatment of Thoracic Empyema: A Population-Based Study.手术和非手术治疗胸腔积脓的结果:一项基于人群的研究。
Ann Thorac Surg. 2019 Nov;108(5):1456-1463. doi: 10.1016/j.athoracsur.2019.05.090. Epub 2019 Jul 26.
9
Lytic Therapy for Retained Traumatic Hemothorax: A Systematic Review and Meta-analysis.创伤性血胸遗留的溶解治疗:系统评价和荟萃分析。
Chest. 2019 Apr;155(4):805-815. doi: 10.1016/j.chest.2019.01.007. Epub 2019 Jan 18.
10
Prevalence and Management of Posttraumatic Retained Hemothorax in a Level 1 Trauma Center.一级创伤中心创伤后血胸残留的患病率及管理
Am Surg. 2018 Sep 1;84(9):e369-e371.